Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,063 GBX | +0.63% | +7.54% | +14.13% |
04:27pm | AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement | MT |
02:55pm | ASTRAZENECA : JP Morgan maintains a Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.13% | 231B | |
+26.58% | 661B | |
+27.40% | 566B | |
-6.32% | 352B | |
+20.30% | 332B | |
+3.21% | 283B | |
+5.17% | 200B | |
-9.04% | 195B | |
-4.90% | 145B | |
-10.70% | 144B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating